Proprietary AI analyst is now available

Fifty 1 Labs Valuation Multiples

Discover Fifty 1 Labs' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Crona, NxGen Brands, Olymp, Nosium and more.

Fifty 1 Labs Overview

About Fifty 1 Labs

Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.


Founded

1998

HQ

United States

Employees

10

Financials (FY)

Revenue: $0K
EBITDA: ($1K)

EV

$554K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Fifty 1 Labs Financials

Fifty 1 Labs reported last fiscal year revenue of $0K and negative EBITDA of ($1K).

In the same fiscal year, Fifty 1 Labs generated $0K in gross profit, ($1K) in EBITDA losses, and had net loss of ($1K).


Fifty 1 Labs P&L

In the most recent fiscal year, Fifty 1 Labs reported revenue of $0K and EBITDA of ($1K).

Fifty 1 Labs is unprofitable as of last fiscal year, with gross margin of 18%, EBITDA margin of (1733%), and net margin of (1733%).

See analyst estimates for Fifty 1 Labs
Last FY20232024202620272028
Revenue$0K$46K$0K
Gross Profit$0K$24K$0K
Gross Margin18%51%18%
EBITDA($1K)($264K)($1K)
EBITDA Margin(1733%)(573%)(1733%)
EBIT Margin(1733%)(573%)(1733%)
Net Profit($1K)($254K)($1K)
Net Margin(1733%)(551%)(1733%)
Net Debt$65K--

Financial data powered by Morningstar, Inc.

Fifty 1 Labs Stock Performance

Fifty 1 Labs has current market cap of $489K, and enterprise value of $554K.


Fifty 1 Labs' stock price is $0.00.

See more trading valuation data for Fifty 1 Labs
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$554K$489K0.0%---$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Fifty 1 Labs Valuation Multiples

Fifty 1 Labs trades at 7690.3x EV/Revenue multiple, and (443.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for Fifty 1 Labs

Fifty 1 Labs Financial Valuation Multiples

As of June 24, 2026, Fifty 1 Labs has market cap of $489K and EV of $554K.

Fifty 1 Labs has a P/E ratio of (391.6x).

Last FY20232024202620272028
EV/Revenuen/m12.0xn/m
EV/EBITDAn/m(2.1x)n/m
EV/EBITn/m(2.1x)n/m
EV/Gross Profitn/m23.6xn/m
P/En/m(1.9x)n/m
EV/FCFn/m70.8xn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Fifty 1 Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Fifty 1 Labs Margins & Growth Rates

In the most recent fiscal year, Fifty 1 Labs reported gross margin of 18%, EBITDA margin of (1733%), and net margin of (1733%).

See estimated margins and future growth rates for Fifty 1 Labs

Fifty 1 Labs Margins

Last FY2024202720282029
Gross Margin18%18%
EBITDA Margin(1733%)(1733%)
EBIT Margin(1733%)(1733%)
Net Margin(1733%)(1733%)
FCF Margin(2550%)(2550%)

Fifty 1 Labs Growth Rates

23/2426/2727/2828/29
Revenue Growth(100%)
Gross Profit Growth(100%)
EBITDA Growth(100%)
EBIT Growth(100%)
Net Profit Growth(100%)
FCF Growth(123%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Fifty 1 Labs Operational KPIs

Fifty 1 Labs' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Fifty 1 Labs
Last FY20232024202620272028
Revenue per Employee$0.0M--
Opex per Employee$0.0M--
S&M Expenses to Revenue-25%-
G&A Expenses to Revenue1751%612%1751%
Opex to Revenue1751%624%1751%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Fifty 1 Labs Competitors

Fifty 1 Labs competitors include Crona, NxGen Brands, Olymp, Nosium, Emergent Health, Momentous Holdings, Ming Le Sports, Fitell, IMD Companies and HitIQ.

Most Fifty 1 Labs public comparables operate across Health & Beauty and Sports & Leisure.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Crona--(37.6x)-
NxGen Brands----
Olymp5.0x-(8.7x)-
Nosium1.5x-(0.9x)-
Emergent Health----
Momentous Holdings--(14.4x)-
Ming Le Sports(438.8x)-2.9x-
Fitell----

This data is available for Pro users. Sign up to see all Fifty 1 Labs competitors and their valuation data.

Start Free Trial

Acquisitions by Fifty 1 Labs

Fifty 1 Labs has acquired 3 companies to date.

Last acquisition by Fifty 1 Labs was on September 30th 2025. Fifty 1 Labs acquired BioSpark for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Fifty 1 Labs

BioSpark
Genetic Networks
Drago Knives
Description
BioSpark is an AI-powered analytics firm based in Tel Aviv, Israel, delivering patient journey insights for oncology. It aggregates real-world data from electronic health records and claims to support pharmaceutical companies, regulators, and nonprofits in optimizing cancer treatment pathways, clinical trial design, and health policy decisions.
Genetic Networks is a computational biology firm offering target identification and drug optimization tools. Its platform integrates genetic data to deliver insights that refine decision-making, mitigate risks, and accelerate development in pharmaceuticals. The company serves biotech researchers with predictive analytics for novel therapies.
Drago Knives is a manufacturer focused on throwing knives designed for precision and durability. The company produces balanced blades suited for target practice and competitions, emphasizing ergonomic handles and high-quality steel construction. Drago models cater to enthusiasts and professionals in the sport of knife throwing.
HQ CountryIsraelUnited StatesUnited States
HQ City
Tel Aviv
Miami, FL
Miami, FL
Deal Date30 Sep 202520 Mar 202518 Jun 2024
Valuationundisclosed$10Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Fifty 1 Labs acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Fifty 1 Labs

When was Fifty 1 Labs founded?Fifty 1 Labs was founded in 1998.
Where is Fifty 1 Labs headquartered?Fifty 1 Labs is headquartered in United States.
How many employees does Fifty 1 Labs have?As of today, Fifty 1 Labs has over 10 employees.
Is Fifty 1 Labs publicly listed?Yes, Fifty 1 Labs is a public company listed on OTCM.
What is the stock symbol of Fifty 1 Labs?Fifty 1 Labs trades under FITY ticker.
When did Fifty 1 Labs go public?Fifty 1 Labs went public in 2004.
Who are competitors of Fifty 1 Labs?Fifty 1 Labs main competitors include Crona, NxGen Brands, Olymp, Nosium, Emergent Health, Momentous Holdings, Ming Le Sports, Fitell, IMD Companies, HitIQ.
What is the current market cap of Fifty 1 Labs?Fifty 1 Labs' current market cap is $489K.
What is the current revenue of Fifty 1 Labs?Fifty 1 Labs' last fiscal year revenue is $0K.
What is the current EV/Revenue multiple of Fifty 1 Labs?Current revenue multiple of Fifty 1 Labs is 7690.3x.
Is Fifty 1 Labs profitable?No, Fifty 1 Labs is not profitable.
How many companies Fifty 1 Labs has acquired to date?As of June 2026, Fifty 1 Labs has acquired 3 companies.
What was the largest acquisition by Fifty 1 Labs?$10M acquisition of Genetic Networks on 20th March 2025 was the largest M&A Fifty 1 Labs has done to date.
What companies Fifty 1 Labs acquired?Fifty 1 Labs acquired Genetic Networks, BioSpark, and Drago Knives.
In how many companies Fifty 1 Labs has invested to date?Fifty 1 Labs hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Fifty 1 Labs

Lists including Fifty 1 Labs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial